Filing Flows

Filing Flows › Protalix BioTherapeutics (PLX) › Who owns the stock

Who owns Protalix BioTherapeutics (PLX) stock

93 funds reported Protalix BioTherapeutics (PLX) shares in their latest 13F filings, worth $34.8M in all. The largest holder is BlackRock ($9.4M). Last quarter 50 funds added to their stakes and 32 cut them.

Largest holders of PLX (13F)Largest holders of PLX (13F)BlackRock$9.4MRenaissance Technologies LLC$2.6MState Street$2.3MGeode Capital Management, LLC$2.3MNorthern Trust$2.1MVanguard Portfolio Management LLC$1.2MStratos Wealth Partners$1.2MDimensional Fund Advisors LP$1.1MGoldman Sachs Group$1.1MMarshall Wace, LLP$1.1M

Largest holders (13F)

FundSharesValueChangeQuarter
BlackRock4,046,650$9.4Mincrease2026-06-30
Renaissance Technologies LLC1,096,000$2.6Mdecrease2026-06-30
State Street983,582$2.3Mincrease2026-06-30
Geode Capital Management, LLC979,995$2.3Mincrease2026-06-30
Northern Trust922,340$2.1Mincrease2026-06-30
Vanguard Portfolio Management LLC510,639$1.2Mincrease2026-06-30
Stratos Wealth Partners500,000$1.2Munchanged2026-06-30
Dimensional Fund Advisors LP493,424$1.1Mincrease2026-06-30
Goldman Sachs Group475,922$1.1Mincrease2026-06-30
Marshall Wace, LLP452,757$1.1Mnew2026-06-30
Vanguard Group488,552$879Kincrease2025-12-31
Citadel Advisors LLC334,227$779Knew2026-06-30
Strs Ohio296,100$690Knew2026-06-30
Bank of New York Mellon232,992$543Kincrease2026-06-30
Main Street Financial Solutions, LLC214,100$499Kunchanged2026-06-30

Protalix BioTherapeutics' latest quarter

Protalix BioTherapeutics, Q2 2026: revenue $19.9M (+27% year over year), operating margin 23.5%, net earnings $3.8M, operating cash flow −$10.4M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most PLX stock?

By the latest 13F filings: BlackRock ($9.4M); Renaissance Technologies LLC ($2.6M); State Street ($2.3M); Geode Capital Management, LLC ($2.3M); Northern Trust ($2.1M).

What is the short interest in PLX?

3,508,555 shares were sold short at the 2026-10-15 settlement, 15.41% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.